The cardioprotective activity of ALM-802 compound was demonstrated in model experiments simulating postinfarction chronic heart failure in rats forming in 90 days after anterior transmural myocardial infarction. ALM-802 decreased the left ventricle and improved its inotropic function (p=0.038). This effect was observed in case of systematic administration of ALM-802 over 28 days (starting from day 91 after infarction modeling). This is apparently the minimum time for the cardioprotective effect of ALM-802 to prevent or treat the resulting heart failure, because short-term systematic therapy (15 days) produced no positive effect.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s10517-021-05152-0 | DOI Listing |
Publication Analysis
Top Keywords
heart failure
12
chronic heart
8
alm-802 compound
8
alm-802
5
choice tactics
4
tactics experimental
4
experimental therapy
4
therapy chronic
4
failure alm-802
4
compound cardioprotective
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!